ESTRELLA IMMUNOPHARMA, INC. Increase (Decrease) in Derivative Liabilities
ESTRELLA IMMUNOPHARMA, INC. (ESLA) reported Increase (Decrease) in Derivative Liabilities of $108.63 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-18.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDerivativeLiabilities · last filed 2026-05-18
- ESTRELLA IMMUNOPHARMA, INC. increase (decrease) in derivative liabilities for the quarter ending 2026-03-31 was $108.63K.
- ESTRELLA IMMUNOPHARMA, INC. increase (decrease) in derivative liabilities for the quarter ending 2025-12-31 was -$28.85K.
- ESTRELLA IMMUNOPHARMA, INC. increase (decrease) in derivative liabilities for the quarter ending 2025-09-30 was $67.04K.
- ESTRELLA IMMUNOPHARMA, INC. increase (decrease) in derivative liabilities for fiscal 2025 was $38.19K.
| Period end | Increase (Decrease) in Derivative Liabilities 3 month | Increase (Decrease) in Derivative Liabilities 6 month | Increase (Decrease) in Derivative Liabilities 9 month | Increase (Decrease) in Derivative Liabilities 12 month |
|---|---|---|---|---|
| 2026-03-31 | $108.63K 10-Q · filed 2026-05-18 | $79.78K derived: sum of 2 quarters · filed 2026-05-18 | $146.82K derived: sum of 3 quarters · filed 2026-05-18 | |
| 2025-12-31 | -$28.85K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $38.19K derived: sum of 2 quarters · filed 2026-03-18 | $38.19K 10-K · filed 2026-03-18 | |
| 2025-09-30 | $67.04K 10-Q · filed 2025-11-12 | $67.04K 10-Q · filed 2025-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |